Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 10, 1321 - 1328 (2004)
Published online: 21 November 2004 | doi:10.1038/nm1146
Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
Natalia Issaeva1, Przemyslaw Bozko1, Martin Enge1, Marina Protopopova1, Lisette G G C Verhoef1, Maria Masucci1, Aladdin Pramanik2 & Galina Selivanova1
Abstract
In tumors that retain wild-type p53, its tumor-suppressor function is often impaired as a result of the deregulation of HDM-2, which binds to p53 and targets it for proteasomal degradation. We have screened a chemical library and identified a small molecule named RITA (reactivation of p53 and induction of tumor cell apoptosis), which bound to p53 and induced its accumulation in tumor cells. RITA prevented p53–HDM-2 interaction in vitro and in vivo and affected p53 interaction with several negative regulators. RITA induced expression of p53 target genes and massive apoptosis in various tumor cells lines expressing wild-type p53. RITA suppressed the growth of human fibroblasts and lymphoblasts only upon oncogene expression and showed substantial p53-dependent antitumor effect in vivo. RITA may serve as a lead compound for the development of an anticancer drug that targets tumors with wild-type p53.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Reply to 'NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro'Nature Medicine Correspondence (01 Nov 2005)
Regulation of autophagy by cytoplasmic p53Nature Cell Biology Article (01 Jun 2008)
